| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Dec 6, 2022 | Entact Bio | Series A | — | Biopharma | — |
| Apr 19, 2021 | Adaptate Biotherapeutics | Series A | — | Biotechnology | — |
| Mar 19, 2021 | X4 Pharmaceuticals | Post-IPO Equity | — | Biotechnology | — |
| Jan 7, 2021 | Scorpion Therapeutics | Series B | — | Biotechnology | — |
| Oct 26, 2020 | Scorpion Therapeutics | Series A | — | Biotechnology | — |
| Jan 13, 2015 | Personalis | Series C | — | Biotechnology | — |
| May 16, 2014 | Proteon Therapeutics | Series D | — | Biotechnology | Yes |
| Oct 7, 2013 | Personalis | Series B | — | Biotechnology | Yes |
| Jan 8, 2013 | Labcyte | Series D | — | Alternative Medicine | — |
| Aug 15, 2011 | Personalis | Series A | — | Biotechnology | — |
| Mar 26, 2008 | Labcyte | Series C | — | Alternative Medicine | — |
| Jul 25, 2005 | Labcyte | Series C | — | Alternative Medicine | — |
| Jul 9, 2002 | Labcyte | Series B | — | Alternative Medicine | — |